Clinical Trials Insight: 700043602
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2010
At a glance
- Drugs CB 182804 (Primary)
- Indications Gram-negative infections
- Focus Adverse reactions
- Sponsors Cubist Pharmaceuticals
- 25 Jan 2010 Status changed from recruiting to active, no longer recruiting, according to a Cubist Pharmaceuticals media release.
- 20 Apr 2009 New trial record.